22nd Century Group Reports Second Quarter 2025 Financial Results
1. 22nd Century expands VLN® product launches with new partnerships. 2. FDA supports the new tobacco product standard for VLN® cigarettes. 3. Significant state authorizations for reduced nicotine products increase market access. 4. Company aims for profitable growth with high-margin branded products. 5. Recent financials show stable net losses but reduced debt significantly.